PubMed

Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial.

Borden EC, Holland JF, Dao TL, Gutterman JU, Wiener L, Chang YC, Patel J.

Ann Intern Med. 1982 Jul;97(1):1-6.PMID: 6178335 [PubMed - indexed for MEDLINE]Related articles

Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.

Horning SJ, Merigan TC, Krown SE, Gutterman JU, Louie A, Gallagher J, McCravey J, Abramson J, Cabanillas F, Oettgen H, et al.

Cancer. 1985 Sep 15;56(6):1305-10.PMID: 4027869 [PubMed - indexed for MEDLINE]Related articles

Immunological effects of recombinant interferon-alpha 2 in cancer patients.

Hengst JC, Kempf RA, Kan-Mitchell J, Pham AT, Grunberg SM, Kortes VL, Mitchell MS.

J Biol Response Mod. 1983;2(6):516-27.PMID: 6663321 [PubMed - indexed for MEDLINE]Related articles

Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer.

Quesada JR, Gutterman JU, Hersh EM.

J Interferon Res. 1982;2(4):593-9.PMID: 7142762 [PubMed - indexed for MEDLINE]Related articles

American cancer society Phase I trial of naturally produced beta-interferon.

Hawkins MJ, Krown SE, Borden EC, Krim M, Real FX, Edwards BS, Anderson SA, Cunningham-Rundles S, Oettgen HF.

Cancer Res. 1984 Dec;44(12 Pt 1):5934-8.PMID: 6498851 [PubMed - indexed for MEDLINE]Related articlesFree article

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.

Bergmann L, Fenchel K, Weidmann E, Enzinger HM, Jahn B, Jonas D, Mitrou PS.

Cancer. 1993 Sep 1;72(5):1733-42.PMID: 8348502 [PubMed - indexed for MEDLINE]Related articles

Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.

Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S, et al.

J Biol Response Mod. 1983;2(6):499-515.PMID: 6607323 [PubMed - indexed for MEDLINE]Related articles

Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

Gutterman JU, Fine S, Quesada J, Horning SJ, Levine JF, Alexanian R, Bernhardt L, Kramer M, Spiegel H, Colburn W, Trown P, Merigan T, Dziewanowski Z.

Ann Intern Med. 1982 May;96(5):549-56.PMID: 6176159 [PubMed - indexed for MEDLINE]Related articles

NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).

National Toxicology Program.

Natl Toxicol Program Tech Rep Ser. 1999 Feb;469:1-361.PMID: 12579204 [PubMed - as supplied by publisher]Related articlesFree article

A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans.

Schiller JH, Hank J, Storer B, Borchert AA, Moore KH, Albertini M, Bechhofer R, Wesley O, Brown RR, Bastin AM, et al.

Cancer Res. 1993 Mar 15;53(6):1286-92.PMID: 8443808 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I study of human leukocyte interferon in patients with advanced cancer.

Horning SJ, Levine JF, Meyer M, Merigan TC, Rosenberg SA.

J Biol Response Mod. 1983;2(1):47-56.PMID: 6196450 [PubMed - indexed for MEDLINE]Related articles

Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.

Liljefors M, Nilsson B, Mellstedt H, Frödin JE.

Cancer Immunol Immunother. 2008 Mar;57(3):379-88. Epub 2007 Aug 4.PMID: 17676322 [PubMed - indexed for MEDLINE]Related articles

Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients.

Quesada JR, Gutterman JU.

J Natl Cancer Inst. 1983 Jun;70(6):1041-6.PMID: 6190033 [PubMed - indexed for MEDLINE]Related articles

Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.

Budd GT, Bukowski RM, Miketo L, Yen-Lieberman B, Proffitt MR.

Cancer Chemother Pharmacol. 1984;12(1):39-42.PMID: 6690072 [PubMed - indexed for MEDLINE]Related articles

Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferon.

Besana C, Borri A, Bucci E, Citterio G, Di Lucca G, Fortis C, Matteucci P, Tognella S, Tresoldi M, Baiocchi C, et al.

Eur J Cancer. 1994;30A(9):1292-8.PMID: 7999416 [PubMed - indexed for MEDLINE]Related articles

Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.

Gutterman JU, Blumenschein GR, Alexanian R, Yap HY, Buzdar AU, Cabanillas F, Hortobagyi GN, Hersh EM, Rasmussen SL, Harmon M, Kramer M, Pestka S.

Ann Intern Med. 1980 Sep;93(3):399-406.PMID: 6159812 [PubMed - indexed for MEDLINE]Related articles

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ.

Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44.PMID: 9209739 [PubMed - indexed for MEDLINE]Related articles

Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.

Masci P, Olencki T, Wood L, Rybicki L, Jacobs B, Williams B, Faber P, Bukowski R, Tong K, Borden EC.

Clin Pharmacol Ther. 2007 Mar;81(3):354-61.PMID: 17339865 [PubMed - indexed for MEDLINE]Related articles

Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.

Frasci G, D'Aiuto G, Comella P, Apicella A, Thomas R, Capasso I, Di Bonito M, Cartenì G, Biglietto M, De Lucia L, Maiorino L, Piccolo S, Bianchi U, D'Aniello R, Lapenta L, Comella G.

Breast Cancer Res Treat. 1999 Aug;56(3):239-52.PMID: 10573115 [PubMed - indexed for MEDLINE]Related articles

Interferon activity and its characterization in the sera of patients with head and neck cancer.

Sato M, Yoshida H, Yanagawa T, Yura Y, Urata M, Atsumi M, Furumoto N, Hayashi Y, Takegawa Y.

Cancer. 1984 Oct 1;54(7):1239-51.PMID: 6205740 [PubMed - indexed for MEDLINE]Related articles